Riskpilot← Back to searchSign inGet full accessproVET Nordic ApS
APSActiveCVR 32441238Industrivej 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200911 employees
Revenue 2025
DKK 7,5M
+12% vs 2024
EBITDA margin
39.8%
+14% vs 2024
Equity ratio
68.4%
Financial strength
Net profit 2025
DKK 2,2M
+10% vs 2024
| Revenue | DKK 7,5M | +12% |
| EBITDA | DKK 3M | +14% |
| Net profit | DKK 2,2M | +10% |
| Total assets | DKK 9,6M | +34% |
| Equity | DKK 6,6M | +50% |
| Employees | 11 | — |
Legal name
proVET Nordic ApS
CVR number
32441238
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. september 2009
Share capital
DKK 125.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening.
Company purpose
Selskabets formål er at drive virksomhed med import, salg og markedsføring, handel med veterinær- og landbrugsprodukter samt hermed beslægtet virksomhed.
Address
Industrivej 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.460 | 1.993 | 2.283 | 2.988 | 3.205 | 3.505 | 3.880 | 4.403 | 4.988 | 6.020 | 6.690 | 5.642 | 6.740 | 7.533 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -4.516 | -4.103 | -4.534 |
| EBITDA | 274 | 339 | 328 | 880 | 693 | 720 | 360 | 383 | 635 | 1.178 | 488 | 1.126 | 2.637 | 2.996 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -133 | -98 | -190 |
| EBIT | 274 | 339 | 328 | 880 | 693 | 720 | 360 | 383 | 635 | 1.178 | 488 | 994 | 2.539 | 2.805 |
| Net financials | -5 | -1 | -2 | -2 | -5 | -27 | -32 | -46 | -23 | -49 | -54 | -55 | -6 | -11 |
| Profit before tax | 269 | 338 | 325 | 878 | 688 | 693 | 328 | 337 | 612 | 1.129 | 434 | 939 | 2.532 | 2.795 |
| Tax | 69 | 88 | 83 | 211 | 155 | 155 | 78 | 78 | 137 | 254 | 101 | 213 | 560 | 618 |
| Net profit | 201 | 250 | 242 | 668 | 533 | 537 | 250 | 258 | 475 | 876 | 333 | 726 | 1.972 | 2.177 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.113 | 1.567 | 1.617 | 2.329 | 3.169 | 2.907 | 3.378 | 3.268 | 3.900 | 3.766 | 4.998 | 5.846 | 7.131 | 9.572 |
| Equity | 652 | 903 | 844 | 1.512 | 2.045 | 1.582 | 1.332 | 1.340 | 1.565 | 1.941 | 1.775 | 2.501 | 4.373 | 6.550 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44 | 127 | 0 | 133 | 94 | 55 | 0 |
| Short-term debt | 461 | 664 | 773 | 817 | 1.124 | 1.325 | 2.046 | 1.853 | 2.197 | 1.820 | 3.089 | 3.252 | 2.658 | 2.972 |
| Total debt | 461 | 664 | 773 | 817 | 1.124 | 1.325 | 2.046 | 1.897 | 2.324 | 1.820 | 3.222 | 3.345 | 2.714 | 2.972 |
EBITDA margin
39.8%
This company
15.8%
Market median
+152% vs market
20122025
Equity ratio
68.4%
This company
38.2%
Market median
+79% vs market
20122025
Return on equity
33.2%
This company
18.4%
Market median
+80% vs market
20122025
Net profit margin
28.9%
This company
8.1%
Market median
+257% vs market
20122025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20122025
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AV Management | Management | 2010 | — | — |
CE Management | Management | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2025 | |
CWA HOLDING, HAARBY ApS | Company | 15.0% | 15.0% | 2025 |
VIKÆR HOLDING ApS | Company | 15.0% | 15.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VIKÆR HOLDING ApS
proVET Nordic ApS Board members of proVET Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anita Vikær Lund | Management | 0 companies |
| Charlotte Ella Westergaard Andersen | Management | 0 companies |
| Guillermo Ruiz San Juan | Chairman | 0 companies |